
    
      All pregnant patients scheduled for emergency or elective Caesarean section â‰¥18 years,
      willing and able to provide informed consent and not receiving antibiotics, will be eligible
      for recruitment. Patients will be randomised into receiving kefazolin according to current
      standard of care administered pre-operatively intravenously with placebo (control arm), and
      kefazolin according to current standard of care administered pre-operatively with
      metronidazole 500 mg intravenously pre-operatively. Outcome measures will be surgical site
      infection, urinary tract infection and postpartum endometritis. Five hundred patients will be
      recruited in each arm
    
  